Table of Contents

company-logo

Elicera Therapeutics AB (publ), a clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden. The company's portfolio of products in pipeline includes ELC-100, a Phase I/II drug candidate for neuroendocrine tumors indications; ELC-201, a preclinical drug candidate; ELC-301, a CAR T-cell therapy for the treatment of Non-Hodgkin's B-cell lymphoma; and ELC-401, a preclinical drug candidate glioblastoma multiforme (brain tumor) indications. It also develops iTANK, a technology platform used to optimize the effect of all CAR T-cell therapies under the development and activate killer T-cells against cancer. The company was founded in 2014 and is based in Göteborg, Sweden.

Elicera Therapeutics Dividend Announcement

• Elicera Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Elicera Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Elicera Therapeutics Dividend History

Elicera Therapeutics Dividend Yield

Elicera Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Elicera Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Elicera Therapeutics Financial Ratios

P/E ratio-2.89
PEG ratio0.04
P/B ratio2.32
ROE-87.48%
Payout ratio0.00%
Current ratio4.25
Quick ratio4.25
Cash Ratio4.12

Elicera Therapeutics Dividend FAQ

Does Elicera Therapeutics stock pay dividends?
Elicera Therapeutics does not currently pay dividends to its shareholders.
Has Elicera Therapeutics ever paid a dividend?
No, Elicera Therapeutics has no a history of paying dividends to its shareholders. Elicera Therapeutics is not known for its dividend payments.
Why doesn't Elicera Therapeutics pay dividends?
There are several potential reasons why Elicera Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Elicera Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Elicera Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Elicera Therapeutics a dividend aristocrat?
Elicera Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Elicera Therapeutics a dividend king?
Elicera Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Elicera Therapeutics a dividend stock?
No, Elicera Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Elicera Therapeutics stocks?
To buy Elicera Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Elicera Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.